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LETTERS TO THE EDITORThe Role of ZFYVE27/Protrudin
in Hereditary Spastic Paraplegia
To the Editor: Hereditary spastic paraplegia (HSP) is a he-
reditary condition characterized by selective retrograde de-
generation of corticospinal motor axons and is therefore
a model disease for studying mechanisms of axonal degen-
eration.1 Although HSP is genetically heterogeneous, the
most common form is due to heterozygous mutations in
the SPG4 gene (MIM 604277), encoding the microtubule-
severing protein spastin.2 We read with great interest the
report in The American Journal of Human Genetics of the
identiﬁcation of ZFYVE27 (also known as protrudin) as
a spastin interactor in a two-hybrid screening and the ﬁnd-
ing of a missense mutation (p.G191V) in the protein in
a German family with classical features of autosomal-dom-
inant HSP3. The ZFYVE27 gene (MIM 610244) has been as-
signed the SPG33 gene symbol. The p.G191V mutation
was found to segregate with HSP in the proband’s children
(one healthy and two affected individuals) and was not de-
tected in 210 control chromosomes. The authors do not
specify whether and which known HSP genes were previ-
ously excluded in this family. The p.G191V change does
not fall into any functional domain but was suggested to
provoke a shift in a transmembrane domain of protrudin
and thus to alter proper conformation.3 Immunoﬂuores-
cence experiments showed a slightly different subcellular
localization of the mutant version of protrudin than of
the wild-type, although these studies were based on over-
expression. More interestingly, the authors showed coim-
munoprecipitation experiments suggesting a reduced
binding of mutant protrudin to spastin, thus implying
that at the basis of the disease is a failure of protrudin to
interact with spastin.3
Our interest in protrudin increased evenmorewhen a pa-
per in Science reported a role of protrudin in Rab-11-medi-
ated membrane trafﬁcking.4 When overexpressed, protru-
din promotes outgrowth of cellular projections in HeLa
cells and neurite formation in PC12 cells and primary neu-
rons. Conversely, protrudin downregulation inhibits neu-
rite formation. Protrudin action occurs via preferential
binding to the GDP-bound form of Rab11, suggesting
that it regulates Rab11-dependent membrane recycling to
induce directional membrane trafﬁcking required for neu-
rite formation.4 This study has important implications for
our understanding of the role of protrudin in HSP and also
provides an opportunity to address the functional role of
the p.G191V substitution.
We assessed the functional ability of protrudinG191V to
mediate outgrowth of HeLa cell projections and of neurites
of NSC34 cells (an immortalized murine motoneuronal
cell line). Remarkably, we found no difference in the abilityThof wild-type and mutant protrudin to extend neurites in
NSC34 cells or to elongate HeLa cells in several indepen-
dent experiments (Figures 1A–1D and not shown). Consis-
tent with these ﬁndings, protrudinG191V maintains the
ability to preferentially interact with Rab11-GDP (supplied
to cells as a dominant-negative mutant, Rab11S25N) (Fig-
ure 1E). These data strongly indicate that the p.G191V
change does not lead to loss of function. These results leave
open the possibility that protrudinG191V malfunction is
linked to its failure to interact with spastin. However, we
could coimmunoprecipitate wild-type and mutated pro-
trudin equally well with spastin, in disagreement with re-
sults of Mannan et al.3 (Figure 1F). Our data provide no
clue as to the pathogenic role of the p.G191V mutation.
We searched the SNP database for the ZFYVE27 gene. We
were struck by the ﬁnding that the p.G191V change is
listed as a polymorphism (id rs35077384) with an allele fre-
quency of 0.038 in the APPLERA_GI:AGI_ASL population,
of 0.067 in the HapMap-YRI population, of 0.011 in the
HapMap-JPT population, and of 0.008 in the Hap-Map-
CEU population.
All together, our results cast doubts on the implication of
ZFYVE27/protrudin in HSP, unless incontrovertible patho-
genicmutations are identiﬁed in other families. The classiﬁ-
cation of ZFYVE27 as an HSP disease gene is misleading to
thecommunityofgeneticists interested inHSPmoleculardi-
agnosis andpathogenic studies. This stresses the importance
of accurate functional validation of putative disease-causing
mutations, especially when the mutation is a missense
change and a single family is identiﬁed. It remains of course
possible that the p.G191V change is in linkage disequilib-
rium with the real mutation in the original family or that
it acts as a gene modiﬁer for another HSP gene. Although
we propose removing SPG33 from the list of HSP genes, we
should continue toconsider this gene relevant for theunder-
standing of the pathogenesis of SPG4-related HSP.
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Figure 1. Exploring the Pathogenic
Role of ProtrudinG191V
(A–C) NSC34 cells were transfected with
control GFP, FLAG-protrudin, or FLAG-pro-
trudinG191V vectors. Both wild-type protru-
din and protrudinG191V stimulate neurite
elongation with the same efficiency. The
scale bar represents 50 mm.
(D) Quantification of the percentage of
cells with neurites longer than 30 mm in
the different conditions (means of at least
three independent experiments5 SEM; at
least 450 cells were scored per condition;
*p < 0.05, Student’s t test). The average
length of neurites in these cells was
58.01 mm 5 3.56 for wild-type protrudin
and 59.55 mm5 3.66 for protrudinG191V.
(E) Coimmunoprecipitation experiments
between protrudin and Rab11 show that
both wild-type protrudin and protru-
dinG191V interact with Rab11S25N (GDP-
bound form) but not with Rab11Q70L
(GTP-bound form).
(F) Spastin interacts both with wild-type
protrudin and protrudinG191V. To detect
spastin, we used a specific antibody (S51).Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
Single Nucleotide Polymorphism (SNP) database, http://www.
ncbi.nlm.nih.gov/projects/SNP/
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(HSP).1 The index patient of this HSP family was screened
for mutations in the SPG4 gene (MIM 604277) and was
negative for any mutation.
We identiﬁed ZFYVE27 as spastin-interacting protein in
a yeast two-hybrid screen, then went on to validate the
interaction between spastin and ZFYVE27 in mammalian
cells by coimmunoprecipitation and colocalization
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